Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
Home Editorial Board Current Issue Special Issue Archives Indexing Submit Article
Instruction to Authors Manuscript Charges Copyright Form Model Manuscript Process Flow (Time Frame) FAQ
Reviewer Guidelines Selection of Reviewers Join our Team of Reviewers Apply as Reviewer Reviewer Login
Editorial Review Policy Embargo Policy Ethical Expectations Consent For Identifying Information Informed Consent Manuscript Withdrawal Policy Peer Review Process Plagiarism Policy Ethical Violations Appeal Policy Against Editorial Decision Advertising Policies Authorship Policy
Access Policies Authorship Publication Policy Publication Ethics Complaints Policy Confidential Information Conflicts of Interest Policy Consent for Copyrighted Material Copyright Policy Corrections and Retractions Digital Preservation Policy Research On Human And Animal Studies Open Access Policy
Publication Ethics Contact
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2022 - IJCMAS--ICV 2022: 95.28 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020] For more details click here

Join as a Reviewer

Login as a Reviewer

Indexed in



National Academy of Agricultural Sciences (NAAS)
NAAS Score: *5.38 (2020)
[Effective from January 1, 2020]
For more details click here
ICV 2022: 95.28
Index Copernicus ICI Journals Master List 2022 - IJCMAS--ICV 2022: 95.28
For more details click here
Announcement

See Guidelines to Authors
Current Issues
Download Publication Certificate

Original Research Articles                      Volume : 7, Issue:12, December, 2018
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com /
submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38
Metrics and citations

Int.J.Curr.Microbiol.App.Sci.2018.7(12): 2786-2793
DOI: https://doi.org/10.20546/ijcmas.2018.712.316


Anti-cancerous Activities of Anthocyanins of Banana cv. Nendran (Musa sp.) Flower Bracts against Human Colon and Cervical Cancer Cell Lines

Suman1, K. Kalaimathi1, S. Palanichamy2, R. Sowmiya2,Mayil Vaganan2*, I. Ravi2 and S. Uma2

1Dr. N.G.P. Arts and Science College, Kalapatty, Coimbatore, Tamil Nadu, India
2ICAR-National Research Centre for Banana, Thogamalai Road, Thayanur Post, Tiruchirappalli, Tamil Nadu, India
*Corresponding author
Abstract:

A comparative study on the anticancer effects of anthocyanins derived from banana cv. Nendran flower bracts against human colon (HT-29) and cervical cancer (HeLa) cells were investigated. In vitro assays by MTT, AO/EtBr and MMP revealed that anthocyanins extract inhibited the growth of both HT-29 and HeLa cells. The percentage of cell viability decreased linearly with increment of anthocyanins. The IC50 values for anthocyanins were 41.18 µg/ml for colon cancer cells and 46.50 µg/ml for the cervical cancer cells by MTT assay. The MMP assay indicated IC50 values of 71.18 and 106.5 µg/ml respectively for HT-29 cells and HeLa cells. The study demonstrates that anthocyanins of banana flower bracts are potential anti-cancerous compounds.


Keywords: Banana bracts, Anthocyanins, Colorectal cancer, Cervical cancer, MTT assay

Download this article as Download

How to cite this article:

Suman, R., K. Kalaimathi, R. Suman, S. Palanichamy, R. Sowmiya, M. Mayil Vaganan, I. Ravi and Uma, S. 2018. Anti-cancerous Activities of Anthocyanins of Banana cv. Nendran (Musa sp.) Flower Bracts against Human Colon and Cervical Cancer Cell Lines.Int.J.Curr.Microbiol.App.Sci. 7(12): 2786-2793. doi: https://doi.org/10.20546/ijcmas.2018.712.316
Copyright: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike license.

Citations
Home | Terms of Use | Copyright Form 2012-2020 Copy rights reserved IJCMAS. Powered by ThinkNEXT Technologies